Cite this article
183
Downloads
2
Citations
569
Views
Announcements
Open Access
Review
Percutaneous Tricuspid Valve Repair
Antonio Mangieri1,*, Alessandro Sticchi1, Aisha Gohar1, Damiano Regazzoli1, Fabio Fazzari1, Daniela Pini1, Marta Pellegrino1, Beniamino Pagliaro1, Ferdinando Loiacono1, Mauro Chiarito1, Bernhard Reimers1, Fabien Praz2, Azeem Latib3, Antonio Colombo1
Show Less
1
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy and IRCCS Humanitas Research Hospital, 20089 Rozzano-Milan, Italy
2
Department of Cardiology, Bern University Hospital, University of Bern, 3012 Bern, Switzerland
3
Department of Cardiology, Montefiore Medical Center, Bronx, NY 10466, USA
*Correspondence: antonio.mangieri@gmail.com (Antonio Mangieri)
Academic Editor: Gaston Rodriguez-Granillo
Academic Editor: Gaston Rodriguez-Granillo
Rev. Cardiovasc. Med. 2022, 23(7), 220;
https://doi.org/10.31083/j.rcm2307220
Submitted: 1 March 2022 | Revised: 11 May 2022 | Accepted: 16 May 2022 | Published: 24 June 2022
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract
Tricuspid regurgitation (TR) negatively affects patient outcomes. Surgical tricuspid valve repair/replacement carries a high operative risk and is not a viable option for many high-risk patients. Percutaneous approaches provide an attractive alternative solution for such patients since they represent a valid alternative to open heart surgery without the significant risks carried by surgery. A number of percutaneous devices are currently under clinical development. This review will discuss about the latest development in the field of percutaneous tricuspid valve repair with possible future developments.
Keywords
tricuspid valve
tricuspid regurgitation
percutaneous tricuspid valve repair
heart failure
right ventricle
right heart failure
Figures
Fig. 1.